Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications

Author： Henderson J.M. Carpenter K. Cartwright H. Halliday G.M.

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.123, Iss.7, 2000-07, pp. : 1410-1421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease

By Rizzo Giovanni

Brain, Vol. 131, Iss. 10, 2008-10 ,pp. : 2690-2700

Oxford University Press

Access to resources Recommend Favorite

The Internal Globus Pallidus Is Affected in Progressive Supranuclear Palsy and Parkinson's Disease

By Hardman C.D. Halliday G.M.

Experimental Neurology, Vol. 158, Iss. 1, 1999-07 ,pp. : 135-142

Elsevier

Access to resources Recommend Favorite

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

By Ling Helen

Brain, Vol. 135, Iss. 4, 2012-06 ,pp. : 1141-1153

Oxford University Press

Access to resources Recommend Favorite

Rational therapeutic approaches to progressive supranuclear palsy

By Stamelou Maria

Brain, Vol. 133, Iss. 6, 2010-06 ,pp. : 1578-1590

Oxford University Press

Access to resources Recommend Favorite

A clinical rating scale for progressive supranuclear palsy

By Golbe Lawrence I.

Brain, Vol. 130, Iss. 6, 2007-06 ,pp. : 1552-1565

Oxford University Press

Access to resources Recommend Favorite